Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

19.84
-0.7800-3.78%
Volume:4.74M
Turnover:93.89M
Market Cap:14.73B
PE:-58.43
High:20.50
Open:20.10
Low:19.20
Close:20.62
Loading ...

Truist Financial Remains a Buy on Summit Therapeutics (SMMT)

TIPRANKS
·
03 Jun

Cantor Fitzgerald Remains a Buy on Summit Therapeutics (SMMT)

TIPRANKS
·
03 Jun

BUZZ-U.S. STOCKS ON THE MOVE-RBB Bancorp, Seacoast, GATX

Reuters
·
31 May

Summit Therapeutics Shares Fall 19.1% After Co's Cancer Therapy Fails to Show Statistical Significance in Extending Survival

THOMSON REUTERS
·
30 May

Summit Therapeutics Study Is a Win for China Biopharma Deals. Why the Stock Is Down. -- Barrons.com

Dow Jones
·
30 May

Summit Says Ivonescimab Significantly Improves Progression-Free Survival; Overall Survival Trend Not Statistically Significant -- Shares Drop

MT Newswires Live
·
30 May

BUZZ-Summit Therapeutics falls after mixed data from late-stage cancer trial

Reuters
·
30 May

Summit Therapeutics Shares Reverse Premarket Gains, Last Down 1.9% After Co's Cancer Therapy Fails to Show Statistical Significance in Extending Survival

THOMSON REUTERS
·
30 May

Summit Therapeutics Shares Rise 7.6% Premarket After Positive Data From Cancer Therapy in Global Late-Stage Study

THOMSON REUTERS
·
30 May

Summit Therapeutics announces topline results from Phase 3 HARMONi trial

TIPRANKS
·
30 May

Summit Therapeutics Inc - Ivonescimab Plus Chemotherapy Improves Progression-Free Survival in Egfr-Mutant Nsclc

THOMSON REUTERS
·
30 May

Summit Therapeutics Inc - Ivonescimab Plus Chemotherapy Reduces Disease Progression Risk by 48% VS Only Chemotherapy

THOMSON REUTERS
·
30 May

Summit Therapeutics initiated with a Buy at Clear Street

TIPRANKS
·
22 May

Pfizer Is Jumping Into a Hot Cancer-Drug Race. It May Have Overpaid. -- Barrons.com

Dow Jones
·
20 May

Summit Therapeutics Announces Inducement Grants for New Employees Under Nasdaq Rule 5635(c)(4)

Reuters
·
17 May

Stock Track | Summit Therapeutics Soars 5.15% as TD Cowen Initiates Coverage with Buy Rating

Stock Track
·
09 May

Stock Track | Summit Therapeutics Soars 5.15% as TD Cowen Initiates Coverage with Buy Rating

Stock Track
·
09 May

Summit Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
08 May

TD Cowen Initiates Summit Therapeutics at Buy

MT Newswires Live
·
08 May

U.K. New-Car Sales Fell in April as New Taxes Hit, Industry Body SMMT Says

Dow Jones
·
06 May